The ADVENT Approach Results in Significantly Fewer Complications Than Other Treatments

black checkmark icon
Ethan Handler, MD
January 1, 2024 12:00 PM

Key Takeaways

  • 5× fewer complications than traditional turbinate surgery
  • 94% of procedures performed safely in-office
  • Up to $6,700 in cost savings per patient

Introduction

Turbinate surgery is a common intervention for patients suffering from nasal obstruction. However, traditional surgical techniques—typically performed in hospitals or ASCs—carry measurable risks and substantial costs.

A 2021 study published in The Journal of Laryngology & Otology reported that 3% of patients undergoing endoscopic turbinectomy and 10.7% of those receiving submucosal turbinate resections required emergency department treatment for post-operative bleeding1. These complications create anxiety for patients, disrupt recovery, and increase total care costs by $300–$600 per episode.

ADVENT’s proprietary approach aims to optimize patient outcomes while lowering costs by performing turbinate reduction safely and effectively in a controlled office setting.

Methods

ADVENT conducted an internal review of all endoscopic submucosal resection and ablation procedures performed in 2022.

  • Sample size: 6,517 patients treated across ADVENT clinics.
  • Setting: Predominantly in-office procedures (no general anesthesia).
  • Endpoints measured: Post-procedure complication rate, frequency of emergency or urgent care visits for bleeding, and cost differentials compared to hospital-based procedures.

These outcomes were compared with peer-reviewed data published in Levy et al. (2021), which analyzed post-operative bleeding rates following various turbinate reduction techniques.

Discussion

These results confirm that ADVENT’s in-office approach provides safer and more cost-effective outcomes for turbinate surgery than traditional facility-based care.

The data reinforce that post-operative complications—especially bleeding—can be minimized through careful procedural technique, patient selection, and avoidance of unnecessary general anesthesia. The office-based model also reduces both financial burden and patient anxiety, improving overall satisfaction.

In addition, by eliminating facility-related overhead, ADVENT’s approach contributes to system-level healthcare savings without compromising quality or safety, aligning with broader value-based care initiatives.

Results

No items found.

ADVENT achieved a 0.6% overall complication rate, five times lower than the 3.0%–10.7% rates reported in the Levy study.

  • Only 0.4% of ADVENT patients required emergency or urgent care visits for post-operative bleeding
  • This compares favorably to the 6.5% of patients requiring emergency department care after partial turbinectomy or endoscopic turbinoplasty in the reference study

94% of ADVENT procedures (6,153 patients) were completed in-office, avoiding hospital or ASC facility fees and associated ancillary costs. This setting reduced the average per-case cost by $5,700–$6,700, according to BSG Analytics claims data.

Conclusion

ADVENT’s research demonstrates that innovation in care delivery can achieve superior clinical outcomes at a lower cost.

With complication rates five times lower than published averages and nearly all procedures performed safely in-office, ADVENT’s turbinate reduction protocol sets a new standard for safety, efficiency, and value in nasal surgery.

References

  • 1. Levy, E., Ronnen, O., Sela, E., Layos, E., Eisenbach, N., Ibrahim, N., Dror, A. A., Daoud, A., & Marshak, T. (2021). Inferior Turbinate Reduction: Comparing Post-Operative Bleeding Between Different Surgical Techniques. The Journal of Laryngology & Otology, 1–6.
  • 2. BSGA Employer Data Set – Claims from Jan. 1, 2022, to Dec. 31, 2022.
  • 3. Clinical data provided by ADVENT (2022).
  • 4. Post-procedure complication data provided by ADVENT (2022).
  • 5. The ADVENT Approach: Optimizing Nasal Outcomes at Lower Cost (BSG Analytics analysis of claims data for 262 commercial patients, July 2022).